Last reviewed · How we verify
A Phase 2 Study to Evaluate the Safety and Efficacy of YRA-1909 in Patients With Rheumatoid Arthritis
This is a multicenter, randomized, double-blind phase2 study to evaluate the safety and investigate the efficacy of YRA-1909 in Patients with Rheumatoid Arthritis who are on a stable dose of Methotrexate(MTX) and who have an inadequate response to MTX(MTX-IR).
Details
| Lead sponsor | Yungjin Pharm. Co., Ltd. |
|---|---|
| Phase | PHASE2 |
| Status | COMPLETED |
| Enrolment | 116 |
| Start date | Sat Apr 01 2017 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Tue Nov 19 2019 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- Rheumatoid Arthritis
Interventions
- YRA-1909 low dose
- YRA-1909 mid dose
- YRA-1909 high dose
- Placebo
Countries
South Korea